Versant Venture Management, LLC Long-Term Concentrated

CIK: 0001560009 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 11, 2022

Total Value ($000): $186,975 (100.0% shares, 0.0% debt)

Holdings (10)

— Gritstone Oncology, Inc. 24.5%

Value ($000) $45,796 Shares 3,561,150 Est. Cost $7767.86 Unrealized —

CRSP CRISPR Therapeutics AG 20.2%

Value ($000) $37,781 Shares 498,558 Est. Cost $40.26 Unrealized +117.0%

— Passage Bio, Inc. 16.8%

Value ($000) $31,495 Shares 4,959,769 Est. Cost $17.48 Unrealized —

— Aligos Therapeutics, Inc. 14.7%

Value ($000) $27,543 Shares 2,320,381 Est. Cost $27.65 Unrealized —

— Akero Therapeutics, Inc. 7.0%

Value ($000) $13,065 Shares 617,727 Est. Cost $21200.00 Unrealized —

CRNX Crinetics Pharmaceuticals, Inc. 6.2%

Value ($000) $11,658 Shares 410,360 Est. Cost $17.05 Unrealized +44.6%

— Adverum Biotechnologies, Inc. 4.8%

Value ($000) $8,920 Shares 5,068,233 Est. Cost $9646.10 Unrealized —

— Minerva Surgical Inc. 4.6%

Value ($000) $8,603 Shares 1,673,700 Est. Cost $5.14 Unrealized —

— CymaBay Therapeutics, Inc. 1.0%

Value ($000) $1,838 Shares 543,753 Est. Cost $9871.60 Unrealized —

— Clovis Oncology, Inc. 0.1%

Value ($000) $276 Shares 101,855 Est. Cost $56000.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Gritstone Oncology, Inc.	3,561,150	$45,796	24.5%	$7767.86	—	Common Stock	39868T105
CRSP	CRISPR Therapeutics AG	498,558	$37,781	20.2%	$40.26	+117.0%	Common Shares	H17182108
—	Passage Bio, Inc.	4,959,769	$31,495	16.8%	$17.48	—	Common Stock	702712100
—	Aligos Therapeutics, Inc.	2,320,381	$27,543	14.7%	$27.65	—	Common Stock	01626L105
—	Akero Therapeutics, Inc.	617,727	$13,065	7.0%	$21200.00	—	Common Stock	00973Y108
CRNX	Crinetics Pharmaceuticals, Inc.	410,360	$11,658	6.2%	$17.05	+44.6%	Common Stock	22663K107
—	Adverum Biotechnologies, Inc.	5,068,233	$8,920	4.8%	$9646.10	—	Common Stock	00773U108
—	Minerva Surgical Inc.	1,673,700	$8,603	4.6%	$5.14	—	Common Stock	60343F106
—	CymaBay Therapeutics, Inc.	543,753	$1,838	1.0%	$9871.60	—	Common Stock	23257D103
—	Clovis Oncology, Inc.	101,855	$276	0.1%	$56000.00	—	Common Stock	189464100